"The Parkinson’s Foundation provides information including news about the disease, information about upcoming events, insight into the latest research, and education about what to expect."
Parkinson's News Today: 9 Organizations That Support Parkinson’s Disease Patients and Their Families
The foundation’s Minnesota chapter hosted the 2017 Parkinson Education Series. Erin McGee, the chapter program manager, is quoted.
Are you considering taking the new 23andMe genetic test? This article analyzes the reasons one may have to take the new genetic test. Parkinson’s Foundation CEO John Lehr is quoted.
John L. Lehr, CEO of the Parkinson’s Foundation, discusses their mission and work around the world and the needs of people with Parkinson’s.
Parkinson’s Foundation CEO John Lehr contributed this article regarding the role of the Parkinson's Foundation and the urgency for and improved understanding of treatment of Parkinson's patients.
Parkinson’s Foundation CEO John Lehr is quoted in this article on selling genetic tests for disease risk directly to consumers.
David Malarkey, PhD, of Cary, NC, discusses his excitement to join the Parkinson’s Foundation People with Parkinson’s Advisory Council. Dr. Malarkey has also been supportive of his local Moving Day® NC Triangle.
Our national medical director Michael S. Okun, MD, is quoted in regards to a study analyzing deep brain stimulation in people with early-stage PD presented at the International Congress of Parkinson’s Disease and Movement Disorders.
The first-ever Moving Day® Louisville, which honored the legacy of Muhammad Ali as part of the “I Am Ali Festival,” raised nearly $60,000 for Parkinson’s research.
A team of neuroscientists and engineers has devised a new method of electrical brain stimulation that will allow people with PD to skip brain surgery while reaching deep brain areas. The Foundation’s national medical director, Michael Okun, M.D., shares expert commentary on the study published yesterday in Cell.
Global Kinetics Corporation and the Parkinson's Foundation announced that the first of more than 400 people with PD has been enrolled in the GKC APPRISE clinical study, which is part of the Foundation’s Parkinson's Outcomes Project. Peter Schmidt, Ph.D., Senior Vice President and Chief Mission Officer of the Foundation is quoted.